Optometrists in Berkeley, CA Accepting Medicare
130 Optometrists found. Showing 121 - 130
 Angela Shahbazian, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 230 Minor Hl, Berkeley, CA 94720 Phone: 510-642-2020 |
Laurel Hammang, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 200 Minor Hl, Berkeley, CA 94720 Phone: 510-642-2020 |
Alexa Westerbeck, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 200 Minor Ln, Berkeley, CA 94720 Phone: 510-642-2020 |
 Dr. Sam Lee, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 230 Minor Hall Mc-2020, Berkeley, CA 94720 Phone: 510-642-2020 |
 Walnut Square Optometry Optometrist Medicare: Medicare Enrolled Practice Location: 2118 Vine St, Suite E, Berkeley, CA 94709 Phone: 510-548-3947 Fax: 510-548-3501 |
Tara Pahlevan-chaleshtari Optometrist Medicare: Medicare Enrolled Practice Location: 200 Minor Hall, Berkeley, CA 94720 Phone: 510-642-0945 |
Dennis Stuart Burger, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 200 Minor Hall School Of Optometry, University Of California, Berkeley, CA 94720 Phone: 510-642-2020 Fax: 510-642-8012 |
Dr. Stephen Russell Chun, OD, FAAO Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2414 Shattuck Ave, Berkeley, CA 94704 Phone: 510-843-1228 Fax: 510-524-1062 |
Crystal Wang Wen, OD Optometrist Medicare: Medicare Enrolled Practice Location: 200 Minor Lane, Berkeley, CA 94720 Phone: 510-642-2020 Fax: 510-642-8012 |
Dr. Taras Litvin, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 200 Minor Hl, University Eye Center, Berkeley, CA 94720 Phone: 510-642-2020 |
News Archive
Parents and pupils need to be advised on asbestos exposure in schools
Accident claims solicitors, First Personal Injury, want to see more advice made readily available to parents and pupils about asbestos exposure in schools. The call comes less than a month after a report by the Asbestos Training and Consultancy Association made news for all the wrong reasons.
Results from Phase 2 trial evaluating Nexavar with capecitabine and paclitaxel presented
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced results from two collaborative group-sponsored randomized, double-blind, placebo-controlled Phase 2 trials were presented at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS).
Anaesthetists identify major shortfall in funding for emergency laparotomies
Anaesthetists have identified a major shortfall in funding for emergency laparotomies in England and have called for a national database to establish a more accurate picture of outcomes and costs. Figures published in the May issue of Anaesthesia suggest a shortfall of -300 million per year for emergency midline general surgical laparotomies, 32% of the total cost of care.
FDA approves Salix' METOZOLV ODT for treating diabetic gastroparesis
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the U.S. Food and Drug Administration (FDA) has granted marketing approval for METOZOLV™ ODT (metoclopramide HCl) 5mg and 10mg orally disintegrating tablets. METOZOLV ODT is indicated for the relief of symptoms in adults associated with acute and recurrent diabetic gastroparesis and for the treatment of short-term therapy (4-12 weeks) for adults with symptomatic documented gastroesophageal reflux disease (GERD) who fail to respond to conventional therapy1.
Scientists report that coating stents with vitamin C reduces implants' risks
Every year, more than 1 million people in the U.S. who have suffered heart attacks or chest pain from blocked arteries have little mesh tubes called stents inserted into their blood vessels to prop them open.
› Verified 3 days ago
Optometrists
Chiropractors
Physical Therapists
Occupational Therapists
Podiatrists
Speech-Language Pathologists
Audiologists